tiprankstipranks
Trending News
More News >
Tenet Healthcare (THC)
NYSE:THC
US Market
Advertisement

Tenet Healthcare (THC) Earnings Dates, Call Summary & Reports

Compare
916 Followers

Earnings Data

Report Date
Oct 16, 2025
After Close (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
3.3
Last Year’s EPS
2.93
Same Quarter Last Year
Based on 17 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call was generally positive, highlighting strong financial performance and growth in key segments like USPI and hospitals. The company raised its full-year guidance, supported by robust fundamentals. However, challenges such as volume deceleration and increased denials and disputes were noted, but they were outweighed by the positive aspects.
Company Guidance
During the second quarter of 2025, Tenet Healthcare Corporation reported robust financial outcomes, with net operating revenues reaching $5.3 billion and consolidated adjusted EBITDA of $1.121 billion, marking a 19% increase over the previous year. The adjusted EBITDA margin improved by 280 basis points to 21.3%, supported by strong same-store growth and efficient operations. USPI contributed significantly, with a $498 million adjusted EBITDA, reflecting an 11% increase over the prior year. Same facility revenues rose by 7.7%, highlighted by a 12.6% growth in total joint replacements in ASCs. The hospital segment also saw a 25% growth in adjusted EBITDA to $623 million, with same-store hospital admissions increasing by 1.6% and revenue per adjusted admission rising by 5.2%. The organization enhanced its full-year 2025 adjusted EBITDA guidance to a range of $4.4 to $4.54 billion, indicating an approximate 10% increase from previous guidance. The company also reduced its overhead by downsizing its hospital portfolio and authorized a $1.5 billion increase in its share repurchase program, demonstrating a commitment to shareholder value through disciplined financial management and strategic capital allocation.
Strong Financial Performance
Second quarter 2025 net operating revenues reached $5.3 billion with a consolidated adjusted EBITDA of $1.121 billion, marking a 19% increase over 2024. The adjusted EBITDA margin improved by 280 basis points to 21.3%.
USPI Growth
USPI generated $498 million in adjusted EBITDA, an 11% growth over the previous quarter. Same facility revenues grew by 7.7%, with a 12.6% increase in total joint replacements in ASCs.
Hospital Segment Performance
Hospital segment adjusted EBITDA grew 25% to $623 million with same-store hospital admissions up 1.6%. Revenue per adjusted admission increased by 5.2%.
Share Repurchase Program Expansion
Tenet Healthcare has deployed $1.1 billion to repurchase 7.2 million shares in the first half of 2025. The board authorized a $1.5 billion increase in the share repurchase program.
Raised Full-Year Guidance
The company raised its full-year 2025 adjusted EBITDA guidance to a range of $4.4 to $4.54 billion, an increase of $395 million or 10% at the midpoint.

Tenet Healthcare (THC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

THC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 16, 2025
2025 (Q3)
3.30 / -
2.93
Jul 22, 2025
2025 (Q2)
2.88 / 4.02
2.3174.03% (+1.71)
Apr 29, 2025
2025 (Q1)
3.12 / 4.36
3.2235.40% (+1.14)
Feb 12, 2025
2024 (Q4)
2.95 / 3.44
2.6828.36% (+0.76)
Oct 29, 2024
2024 (Q3)
2.37 / 2.93
1.44103.47% (+1.49)
Jul 24, 2024
2024 (Q2)
1.91 / 2.31
1.4460.42% (+0.87)
Apr 30, 2024
2024 (Q1)
1.45 / 3.22
1.42126.76% (+1.80)
Feb 08, 2024
2023 (Q4)
1.60 / 2.68
1.9636.73% (+0.72)
Oct 30, 2023
2023 (Q3)
1.20 / 1.44
1.440.00% (0.00)
Jul 31, 2023
2023 (Q2)
1.25 / 1.44
1.5-4.00% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

THC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 22, 2025
$174.65$155.97-10.70%
Apr 29, 2025
$123.91$138.35+11.65%
Feb 12, 2025
$138.83$126.19-9.10%
Oct 29, 2024
$139.49$162.76+16.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tenet Healthcare (THC) report earnings?
Tenet Healthcare (THC) is schdueled to report earning on Oct 16, 2025, After Close (Confirmed).
    What is Tenet Healthcare (THC) earnings time?
    Tenet Healthcare (THC) earnings time is at Oct 16, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is THC EPS forecast?
          THC EPS forecast for the fiscal quarter 2025 (Q3) is 3.3.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis